Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism.
- Author:
Joong Seok KIM
1
;
Dong Woo RYU
;
Ju Hee OH
;
Yang Hyun LEE
;
Sung Jin PARK
;
Kipyung JEON
;
Jong Yun LEE
;
Seong Hee HO
;
Jungmin SO
;
Jin Hee IM
;
Kwang Soo LEE
Author Information
- Publication Type:Original Article
- Keywords: Parkinson's disease; drug-induced parkinsonism; cardiovascular autonomic dysfunction
- MeSH: Antipsychotic Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Humans; Hypertension; Hypotension, Orthostatic; Parkinson Disease; Parkinsonian Disorders*; Tilt-Table Test
- From:Journal of Clinical Neurology 2017;13(1):15-20
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND PURPOSE: Recent studies have shown that several nonmotor symptoms differ between Parkinson's disease (PD) and drug-induced parkinsonism (DIP). However, there have been no reports on cardiovascular autonomic function in DIP, and so this study investigated whether cardiovascular autonomic function differs between PD and DIP patients. METHODS: This study consecutively enrolled 20 DIP patients, 99 drug-naïve PD patients, and 25 age-matched healthy controls who underwent head-up tilt-table testing and 24-h ambulatory blood pressure monitoring. RESULTS: Orthostatic hypotension was more frequent in patients with PD or DIP than in healthy controls. In DIP, orthostatic hypotension was associated with the underlying psychiatric diseases and neuroleptics use, whereas prokinetics were not related to orthostatic hypotension. The supine blood pressure, nighttime blood pressure, and nocturnal blood pressure dipping did not differ significantly between the DIP and control groups. Supine hypertension and nocturnal hypertension were more frequent in PD patients than in controls. CONCLUSIONS: The included DIP patients frequently exhibited orthostatic hypotension that was associated with the underlying diseases as well as the nature of and exposure time to the offending drugs. Clinicians should individualize the manifestations of DIP according to underlying diseases as well as the action mechanism of and exposure time to each offending drug.
